
    
      This multicenter, randomized, double-blind, placebo-controlled and parallel clinical trial is
      to observe the efficacy and safety of the Acetyl-L-Carnitine Hydrochloride enteric-coated
      tablets in treatment of peripheral sensory neuropathy that anti-cancer chemotherapeutics
      induce.
    
  